BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 38274274)

  • 1. Metabolic control of induced pluripotency.
    Sinenko SA; Tomilin AN
    Front Cell Dev Biol; 2023; 11():1328522. PubMed ID: 38274274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.
    Ishida T; Nakao S; Ueyama T; Harada Y; Kawamura T
    Inflamm Regen; 2020; 40():8. PubMed ID: 32426078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting transcriptome landscapes of rabbit pluripotent stem cells in vitro and in vivo.
    Schmaltz-Panneau B; Jouneau L; Osteil P; Tapponnier Y; Afanassieff M; Moroldo M; Jouneau A; Daniel N; Archilla C; Savatier P; Duranthon V
    Anim Reprod Sci; 2014 Sep; 149(1-2):67-79. PubMed ID: 25059199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
    Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
    Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming.
    Nishimura K; Fukuda A; Hisatake K
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation.
    Jasra IT; Cuesta-Gomez N; Verhoeff K; Marfil-Garza BA; Dadheech N; Shapiro AMJ
    Front Endocrinol (Lausanne); 2023; 14():1236472. PubMed ID: 37929027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pkm2 can enhance pluripotency in ESCs and promote somatic cell reprogramming to iPSCs.
    Qin S; Yang D; Chen K; Li H; Zhang L; Li Y; Le R; Li X; Gao S; Kang L
    Oncotarget; 2017 Oct; 8(48):84276-84284. PubMed ID: 29137422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?
    Lopes C; Rego AC
    Mol Neurobiol; 2017 Apr; 54(3):1858-1873. PubMed ID: 26892627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WD repeat domain 82 (Wdr82) facilitates mouse iPSCs generation by interfering mitochondrial oxidative phosphorylation and glycolysis.
    Cui G; Zhou J; Sun J; Kou X; Su Z; Xu Y; Liu T; Sun L; Li W; Wu X; Wei Q; Gao S; Shi K
    Cell Mol Life Sci; 2023 Jul; 80(8):218. PubMed ID: 37470863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.
    Hsu YC; Chen CT; Wei YH
    Biochim Biophys Acta; 2016 Apr; 1860(4):686-93. PubMed ID: 26779594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs.
    Zhao MT; Chen H; Liu Q; Shao NY; Sayed N; Wo HT; Zhang JZ; Ong SG; Liu C; Kim Y; Yang H; Chour T; Ma H; Gutierrez NM; Karakikes I; Mitalipov S; Snyder MP; Wu JC
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11111-E11120. PubMed ID: 29203658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of mice derived from induced pluripotent stem cells.
    Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
    J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
    Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
    Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
    Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic Reprogramming-Above and Beyond Pluripotency.
    Meir YJ; Li G
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.
    Hsu YC; Wu YT; Tsai CL; Wei YH
    Exp Biol Med (Maywood); 2018 Mar; 243(6):563-575. PubMed ID: 29557214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-specificity Tyrosine Phosphorylation-regulated Kinase Inhibitor ID-8 Promotes Human Somatic Cell Reprogramming by Activating PDK4 Expression.
    Xu J; Fang S; Wang N; Li B; Huang Y; Fan Q; Shi J; Liu H; Shao Z
    Stem Cell Rev Rep; 2022 Aug; 18(6):2074-2087. PubMed ID: 35080746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gene expression profiles of induced pluripotent stem cells (iPSCs) generated by a non-integrating method are more similar to embryonic stem cells than those of iPSCs generated by an integrating method.
    Liu Y; Cheng D; Li Z; Gao X; Wang H
    Genet Mol Biol; 2012 Jul; 35(3):693-700. PubMed ID: 23055811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK-STAT3 and somatic cell reprogramming.
    Tang Y; Tian XC
    JAKSTAT; 2013 Oct; 2(4):e24935. PubMed ID: 24470976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.